Penta-O-galloyl-beta-D-glucose induces S- and G1-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1

Carcinogenesis

Volumn 30, Issue 5, 2009, Pages 818-823

  Hu, Hongbo ^a,b   Zhang, Jinhui ^a   Lee, Hyo Jeong ^a,c   Kim, Sung Hoon ^a,c   Lü, Junxuan ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; BROXURIDINE; CYCLIN D1; DNA; DNA DIRECTED DNA POLYMERASE ALPHA; GLUCOSE PENTAGALLATE; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION;

AMINO ACID CHLOROMETHYL KETONES; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN D1; DNA REPLICATION; HUMANS; HYDROLYZABLE TANNINS; MALE; POLY(ADP-RIBOSE) POLYMERASES; PROSTATIC NEOPLASMS;

EID: 65549106509     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp059     Document Type: Article

References (17)

1. Gupta,S. et al. (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl Acad. Sci. USA, 98, 10350-10355.
2. Lambert,J.D. et al. (2005) Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations. Am. J. Clin. Nutr., 81, 284S-291S.
3. Singh,R.P. et al. (2006) Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr. Relat. Cancer, 13, 751-778.
4. Hu,H. et al. (2008) Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol. Cancer Ther., 7, 2681-2691.
5. Pan,M.H. et al. (1999) Induction of apoptosis by penta-O-galloyl-beta-D-glucose through activation of caspase-3 in human leukemia HL-60 cells. Eur. J. Pharmacol., 381, 171-183.
6. Chen,W.J. et al. (2004) Induction of G1 arrest and apoptosis in human jurkat T cells by pentagalloylglucose through inhibiting proteasome activity and elevating p27Kip1, p21Cip1/WAF1, and Bax proteins. J. Biol. Chem., 279, 13496-13505.
7. Chen,W.J. et al. (2003) Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Biochem. Pharmacol., 65, 1777-1785.
8. Hua,K.T. et al. (2006) Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/ Akt pathway in human breast cancer MCF-7 cells. Mol. Carcinog., 45, 551-560.
9. Huh,J.E. et al. (2005) Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: Roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis, 26, 1436-1445.
10. Ikegami,S. et al. (1978) Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha. Nature, 275, 458-460.
11. Borel,F. et al. (2002) Prolonged arrest of mammalian cells at the G1/S boundary results in permanent S phase stasis. J. Cell Sci., 115, 2829-2838.
12. Jiang,C. et al. (2001) Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res., 61, 3062-3070.
13. Dulic,V. et al. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023.
14. Jemal,A. et al. (2008) Cancer statistics, 2008. CA Cancer J. Clin., 58, 71-96.
15. Klein,E.A. (2006) Chemoprevention of prostate cancer. Annu. Rev. Med. 57, 49-63.
16. Hollstein,M. et al. (1991) p53 mutations in human cancers. Science, 253, 49-53.
17. Olivier,M. et al. (2004) TP53 mutation spectra and load: A tool for generating hypotheses on the etiology of cancer. IARC Sci. Publ. 247-270.